← Back to Search

Radiation Therapy

Single-Fraction Palliative Radiation Therapy for Cancer (SFPRT Trial)

N/A
Waitlist Available
Research Sponsored by Care Partners
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Solid Tumor Malignancies and Multiple Myeloma with Bone Metastases and Associated Bone Pain Enrolled in Hospice
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights

SFPRT Trial Summary

This trial will study whether a single dose of radiation therapy can improve quality of life for cancer patients with bone metastases who are enrolled in hospice care.

SFPRT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

SFPRT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Opioid Use for Pain Management
Secondary outcome measures
Improved Activities of Daily Living
Improved Quality of Life Measures

SFPRT Trial Design

1Treatment groups
Experimental Treatment
Group I: Single-Fraction Palliative RTExperimental Treatment1 Intervention
Single-Fraction Palliative Radiation Therapy Adminstration

Find a Location

Who is running the clinical trial?

OHSU Knight Cancer InstituteOTHER
225 Previous Clinical Trials
2,090,440 Total Patients Enrolled
Oregon Health and Science UniversityOTHER
966 Previous Clinical Trials
6,845,720 Total Patients Enrolled
Care PartnersLead Sponsor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~6 spots leftby Mar 2025